144 related articles for article (PubMed ID: 38664275)
21. Antibiotic prophylaxis for transrectal prostate biopsy.
Zani EL; Clark OA; Rodrigues Netto N
Cochrane Database Syst Rev; 2011 May; (5):CD006576. PubMed ID: 21563156
[TBL] [Abstract][Full Text] [Related]
22. Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy--should we reassess our practices for antibiotic prophylaxis?
Steensels D; Slabbaert K; De Wever L; Vermeersch P; Van Poppel H; Verhaegen J
Clin Microbiol Infect; 2012 Jun; 18(6):575-81. PubMed ID: 21958149
[TBL] [Abstract][Full Text] [Related]
23. Antibiotic prophylaxis with intravenous ceftriaxone and fluoroquinolone reduces infectious complications after transrectal ultrasound-guided prostatic biopsy.
Lee C; You D; Jeong IG; Hong JH; Choo MS; Ahn H; Ahn TY; Kim CS
Korean J Urol; 2015 Jun; 56(6):466-72. PubMed ID: 26078845
[TBL] [Abstract][Full Text] [Related]
24. Trial Comparing a Combined Regimen of Amikacin and Ciprofloxacin to Ciprofloxacin Alone as Transrectal Prostate Biopsy Prophylaxis in the Era of High Fluoroquinolone-Resistant Rectal Flora.
Son KC; Chung HS; Jung SI; Kim MS; Hwang EC; Kim JW; Kwon DD
J Korean Med Sci; 2018 Apr; 33(15):e113. PubMed ID: 29629517
[TBL] [Abstract][Full Text] [Related]
25. Rectal Culture-Based Versus Empirical Antibiotic Prophylaxis to Prevent Infectious Complications in Men Undergoing Transrectal Prostate Biopsy: A Randomized, Nonblinded Multicenter Trial.
Tops SCM; Kolwijck E; Koldewijn EL; Somford DM; Delaere FJM; van Leeuwen MA; Breeuwsma AJ; de Vocht TF; Broos HJHP; Schipper RA; Steffens MG; Teerenstra S; Wegdam-Blans MCA; de Brauwer E; van den Bijllaardt W; Leenders ACAP; Sedelaar JPM; Wertheim HFL
Clin Infect Dis; 2023 Apr; 76(7):1188-1196. PubMed ID: 36419331
[TBL] [Abstract][Full Text] [Related]
26. The Role of Ciprofloxacin Resistance and Extended-spectrum beta-lactamase (ESBL) Positivity in Infective Complications Following Prostate Biopsy.
Korkmaz N; Gurbuz Y; Sandikci F; Kul G; Tutuncu EE; Sencan I
Urol J; 2020 Mar; 17(2):192-197. PubMed ID: 31364100
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and characteristics of fecal antimicrobial-resistant Escherichia coli in a cohort of Japanese men undergoing prostate biopsy.
Kamei J; Yagihara Y; Kume H; Horiuchi T; Sato T; Nakagawa T; Fujimura T; Fukuhara H; Moriya K; Homma Y
Int J Urol; 2017 Apr; 24(4):295-300. PubMed ID: 28222483
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Complication Rates with Antibiotic Prophylaxis with Cefpodoxime Versus Fluoroquinolones After Transrectal Prostate Biopsy.
Wenzel M; Welte MN; Theissen LH; Wittler C; Hoeh B; Humke C; Preisser F; Würnschimmel C; Tilki D; Graefen M; Roos FC; Becker A; Karakiewicz PI; Chun FKH; Kluth LA; Mandel P
Eur Urol Focus; 2021 Sep; 7(5):980-986. PubMed ID: 33358884
[TBL] [Abstract][Full Text] [Related]
29. Intramuscular gentamicin improves the efficacy of ciprofloxacin as an antibiotic prophylaxis for transrectal prostate biopsy.
Ho HS; Ng LG; Tan YH; Yeo M; Cheng CW
Ann Acad Med Singap; 2009 Mar; 38(3):212-6. PubMed ID: 19347074
[TBL] [Abstract][Full Text] [Related]
30. The effectiveness of targeted relative to empiric prophylaxis on infectious complications after transrectal ultrasound-guided prostate biopsy: a meta-analysis.
Scott S; Harris PN; Williamson DA; Liss MA; Doi SAR; Roberts MJ
World J Urol; 2018 Jul; 36(7):1007-1017. PubMed ID: 29453690
[TBL] [Abstract][Full Text] [Related]
31. Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy.
Liss MA; Taylor SA; Batura D; Steensels D; Chayakulkeeree M; Soenens C; Rao GG; Dash A; Park S; Patel N; Woo J; McDonald M; Nseyo U; Banapour P; Unterberg S; Ahlering TE; Van Poppel H; Sakamoto K; Fierer J; Black PC
J Urol; 2014 Dec; 192(6):1673-8. PubMed ID: 24928266
[TBL] [Abstract][Full Text] [Related]
32. Predictors of Infectious Complications after Targeted Prophylaxis for Prostate Needle Biopsy.
Papagiannopoulos D; Abern M; Wilson N; O'Block N; Raff L; Coogan C; Latchamsetty KC
J Urol; 2018 Jan; 199(1):155-160. PubMed ID: 28807644
[TBL] [Abstract][Full Text] [Related]
33. Transrectal povidone-iodine efficiency in reducing infections occurring after transrectal ultrasound guided biopsy of the prostate.
Siyez E
Medicine (Baltimore); 2021 Oct; 100(41):e27539. PubMed ID: 34731153
[TBL] [Abstract][Full Text] [Related]
34. Letter to the editor about "Cotrimoxazole and targeted antibiotic prophylaxis for transrectal prostate biopsy: a single-center study".
Cao Q; Chen Y; Feng Y; Cao G
World J Urol; 2024 May; 42(1):320. PubMed ID: 38743161
[No Abstract] [Full Text] [Related]
35. Extended-spectrum β-lactamase in the rectal flora of patients undergoing transrectal prostate biopsy: a study of the prevalence in a major metropolitan hospital.
Sewell J; Chow K; De Sousa A; Sapre N; Norris B; Namdarian B; Sinickas V; Huang JG; Anderson P
BJU Int; 2019 May; 123 Suppl 5():43-46. PubMed ID: 31012990
[TBL] [Abstract][Full Text] [Related]
36. Comparison of ciprofloxacin versus fosfomycin versus fosfomycin plus trimethoprim/sulfamethoxazole for preventing infections after transrectal prostate biopsy.
Bovo A; Kwiatkowski M; Manka L; Wetterauer C; Fux CA; Cattaneo M; Wyler SF; Prause L
World J Urol; 2024 May; 42(1):356. PubMed ID: 38806739
[TBL] [Abstract][Full Text] [Related]
37. Modification of antimicrobial prophylaxis based on rectal culture results to prevent fluoroquinolone-resistant Escherichia coli infections after prostate biopsy.
Suwantarat N; Dumford DM; Ponce-Terashima R; Kundrapu S; Zabarsky TF; Zhu H; Donskey CJ
Infect Control Hosp Epidemiol; 2013 Sep; 34(9):973-6. PubMed ID: 23917913
[TBL] [Abstract][Full Text] [Related]
38. Fosfomycin Trometamol for the Prevention of Infectious Complications After Prostate Biopsy: A Consensus Statement by an International Multidisciplinary Group.
Bjerklund Johansen TE; Kulchavenya E; Lentz GM; Livermore DM; Nickel JC; Zhanel G; Bonkat G
Eur Urol Focus; 2022 Sep; 8(5):1483-1492. PubMed ID: 34920977
[TBL] [Abstract][Full Text] [Related]
39. Prevention of infectious complications after prostate biopsy procedure.
Togo Y; Yamamoto S
Int J Urol; 2017 Jul; 24(7):486-492. PubMed ID: 28556409
[TBL] [Abstract][Full Text] [Related]
40. The augmented prophylactic antibiotic could be more efficacious in patients undergoing transrectal prostate biopsy: a systematic review and meta-analysis.
Yang L; Tang Z; Gao L; Li T; Chen Y; Liu L; Han P; Li X; Dong Q; Wei Q
Int Urol Nephrol; 2016 Aug; 48(8):1197-1207. PubMed ID: 27160220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
